← FDA DRUG APPROVALS

FDA ANDA · ANDA088816

PROMETHAZINE VC W/ CODEINE

Sponsor: CENCI

APPLICATION
ANDA088816
TYPE
ANDA
ORIGINAL APPROVAL
1985-11-22
LATEST ACTION
1996-10-23
ROUTE
ORAL
DOSAGE FORM
SYRUP
MARKETING STATUS
Discontinued

Products

PROMETHAZINE VC W/ CODEINEDiscontinued
CODEINE PHOSPHATE 10MG/5ML, PHENYLEPHRINE HYDROCHLORIDE 5MG/5ML, PROMETHAZINE HYDROCHLORIDE 6.25MG/5ML · SYRUP · ORAL

Approval history

1996-10-23Labeling · Supplement 7AP
1994-05-13Labeling · Supplement 6AP
1993-02-26Labeling · Supplement 2AP
1991-11-14Labeling · Supplement 3AP
1985-11-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →